Keep your current prescription
Table of Contents What defines non-response to GLP-1 therapy Common causes of poor response Identifying modifiable factors Next-step clinical strategies What Defines Non-Response to GLP-1 Therapy in Practice Patients considered non-responders to GLP-1 therapy typically fail to achieve meaningful reductions in HbA1c or body weight after an adequate trial period
Fangming Chen, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
GLP-UP GLP-1 Support Supplement A daily capsule formula built around clinically studied ingredients to support natural GLP-1 activity, appetite awareness, and gut health
Relatively, exenatide ER was therefore considered 65% as efficacious as once-weekly semaglutide 1.0 mg at bringing patients to target, while dulaglutide 0.75 mg and 1.5 mg were respectively 79% and 97% as efficacious as once-weekly semaglutide 0.5 mg, and 70% and 87% as efficacious as once-weekly semaglutide 1 mg in bringing patients to an HbA1c of lower than 7.0% (Figs
This innovative injectable treatment can also eliminate the need for more invasive treatment since it is used to destroy fat and improve the appearance of cellulite